CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial Is Acute heart failure a distinctive disorder? An analysis from BIOSTAT-CHF Diagnosis of Nonischemic Stage B Heart Failure in Type 2 Diabetes Mellitus: Optimal Parameters for Prediction of Heart Failure Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5) Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative review Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial The spectrum of heart failure: value of left ventricular ejection fraction and its moving trajectories Fluid Volume Overload and Congestion in Heart Failure: Time to Reconsider Pathophysiology and How Volume Is Assessed

Review Article2006 Jun 20;113(24):2851-60.

JOURNAL:Circulation. Article Link

Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction

Goldberg LR, Jessup M. Keywords: Stage B Heart Failure; LVEF; left ventricular systolic dysfunction;

FULL TEXT PDF